Delivery Order SPE2DB20D3103-SPE2DB21FN3D8
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,374.53, is a delivery order for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" and has a completion date of February 24, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for a Prime Vendor Pharmaceutical Branch-Philadelphia delivery order valued at $4,632.00, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a performance period through May 20, 2021 and is a firm fixed price delivery order. Amerisourcebergen, through its parent company Cencora, Inc., holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,854.80 delivery order contract is for the Prime Vendor Pharmaceutical Branch in Philadelphia, with a completion date of September 2, 2020. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical....
- This federal contract award is for a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,730.84 firm fixed-price contract is for a prime vendor pharmacy program serving the DLA's Philadelphia branch, with an ultimate completion date of August 19, 2020. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a Prime Vendor Pharmacy Branch for the Defense Logistics Agency (DLA) in Philadelphia. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,991.03 and a completion date of February 3, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a Prime Vendor Pharmacy Branch in Philadelphia. The $47,175.89 delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00, which runs through November 2026. This IDC enables Amerisourcebergen to efficiently provide a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,712.34 firm fixed-price delivery order is for a Prime Vendor Pharmacy Branch in Philadelphia, with a completion date of June 19, 2020. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., has a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the provision of a prime vendor pharmaceutical branch in Philadelphia for the Defense Logistics Agency (DLA). The $11,636.45 delivery order contract has a firm fixed price and runs through November 2020. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,067.79, is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with an ultimate completion date of April 16, 2021. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $8,642.21 firm fixed-price delivery order is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with a completion date of September 16, 2020. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FN3D8Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,168.15, is a delivery order for a Prime Vendor Pharmaceutical Branch in Philadelphia. The contract has a firm fixed price pricing type and an ultimate completion date of April 19, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.2k | 4/16/21 |